Carregant...
Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
INTRODUCTION: Clinical trials in Alzheimer's disease are aimed at early stages of disease, including preclinical Alzheimer's disease. The high cost and time required to screen large numbers of participants for Aβ pathology impede the development of novel drugs. This study's objective...
Guardat en:
| Publicat a: | Alzheimers Dement (Amst) |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045949/ https://ncbi.nlm.nih.gov/pubmed/27722193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2016.07.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|